Skip to main content
SpringerLink
Log in

Radioguided sentinel lymph node dissection in patients with localised prostate carcinoma: influence of the dose of radiolabelled colloid to avoid failure of the procedure

  • Original article
  • Published:
European Journal of Nuclear Medicine and Molecular Imaging Aims and scope Submit manuscript

Abstract

Introduction

The purpose of this study was to determine the role of the injected dose of tracer in the non-detection of pelvic sentinel lymph nodes (SLN) in patients with prostate carcinoma.

Methods

Data were evaluated from 100 patients (age range 43–77, mean 63 years). The first 72 patients (group 1) received 2 × 0.3 ml of 30 MBq-nanocolloid-99 mTc and the remaining 28 patients (group 2) received 2 × 0.3 ml of 100 MBq. Surgery consisted of the detection and dissection of lymph nodes identified as sentinel nodes, followed by an extended lymphadenectomy.

Results

SLNs were located in the interiliac group in 54.2% of patients, in the obturator fossa in 30.7%, in the external iliac group in 10.9% and in the common iliac group in 4.2% of cases. Lymph node involvement was observed in 12% of patients. But there was a 30.6% (22/72) failure rate of the SLN procedure in group 1 and 7.1% (2/28) in group 2. An increased risk of unsuccessful SLN procedure was statistically associated with the low dose of MBq-nanocolloids (p < 0.017). Statistical correlation is also found after the exclusion of the first 30 patients from the study (learning phase of the team) (p < 0.034). None of the other parameters showed a statistical association (age, p < 0.9; Gleason score, p < 0.3; grade pT, p < 0.7). A higher grade or a greater extension of cancer inside the prostate are not responsible for the failure of the SLN procedure.

Conclusion

It seems necessary to inject at least 200 MBq inside the prostate to avoid a failed SLN procedure.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. El-Galley RE, Keane TE, Petros JA, Sanders WH, Clarke HS, Cotsonis GA, et al. Evaluation of staging lymphadenectomy in prostate cancer. Urology 1998;52:663–667.

    Article  PubMed  CAS  Google Scholar 

  2. Haese A, Epstein JI, Huland H, Partin AW. Validation of a biopsy-based pathologic algorithm for predicting lymph node metastases in patients with clinically localized prostate carcinoma. Cancer 2002;95:1016–1021.

    Article  PubMed  Google Scholar 

  3. Häcker A, Jeschke S, Leeb K, Prammer K, Ziegerhofer J, Sega W, et al. Detection of pelvic lymph node metastases in patients with clinically localized prostate cancer: comparison of [18F]fluorocholine positron emission tomography-computerized tomography and laparoscopic radioisotope guided sentinel lymph node dissection. J Urol 2006;176:2014–2019.

    Article  PubMed  Google Scholar 

  4. Harisinghani MG, Barentsz J, Hahn PF, Deserno WM, Tabatabaei S, Hulsbergen van de Kaa C, et al. Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. N Engl J Med 2003;348:2491–2499.

    Article  PubMed  Google Scholar 

  5. Weckermann D, Dorn R, Trefz M, Wagner T, Wawroschek F, Harzmann R. Sentinel lymph node dissection for prostate cancer: experience with more than 1,000 patients. J Urol 2007;177:916–920.

    Article  PubMed  Google Scholar 

  6. American Joint Committee on Cancer. Cancer staging handbook: TNM classification of malignant tumors, 6th edn. Berlin Heidelberg New York: Springer; 2002.

    Google Scholar 

  7. Gandwindt U, Paulsen F, Corvin S, Hundt I, Alber M, Frey B, et al. Optimized coverage of high-risk adjuvant lymph node areas in prostate cancer using a sentinel node-based, intensity-modulated radiation therapy technique. Int J Rad Oncol Biol Phys 2007;67:347–355.

    Google Scholar 

  8. Beri A, Janetschek G. Technology insight: radioguided sentinel lymph node dissection in the staging of prostate cancer. Nature Clin Pract Urol 2006;3:602–610.

    Article  Google Scholar 

  9. Corvin S, Schilling D, Eichhorn K, Hundt I, Hennenlotter J, Anastasiadis AG, et al. Laparoscopic sentinel lymph node dissection—a novel technique for the staging of prostate cancer. Eur Urol 2006;49:280–285.

    Article  PubMed  Google Scholar 

  10. Corvin S, Schilling D, Anastasiadis AG, Bares R, Stenzl A, Kuczyk M. Radioisotope guided pelvic lymph node dissection for prostate cancer staging. Eur Urol Suppl 2005;4:25–27.

    Article  Google Scholar 

  11. Jeschke S, Nambirajan T, Leeb K, Ziegerhofer J, Sega W, Janetschek G. Detection of early lymph node metastases in prostate cancer by laparoscopic radioisotope guided sentinel lymph node dissection. J Urol 2005;173:1943–1946.

    Article  PubMed  Google Scholar 

  12. Weckermann D, Goppelt M, Dorn R, Wawroschek F, Harzmann R. Incidence of positive pelvic lymph nodes in patients with prostate cancer, a prostate-specific antigen (PSA) level of ≤10 ng/ml and biopsy Gleason score of ≤6, and their influence on PSA progression-free survival after radical prostatectomy. BJU Int 2006;97:1173–1178.

    Article  PubMed  Google Scholar 

  13. Krengli M, Ballarè A, Cannillo A, Rudoni M, Kocjancic E, Gianfranco L, et al. Potential advantage of studying the lymphatic drainage by sentinel node technique and SPECT-CT image fusion for pelvic irradiation of prostate cancer. Int J Rad Oncol Biol Phys 2006;66:1100–1104.

    Google Scholar 

  14. Takashima H, Egawa M, Imao T, Fukuda M, Yokoyama K, Namiki M. Validity of sentinel lymph node concept for patients with prostate cancer. J Urol 2004;171:2268–2271.

    Article  Google Scholar 

  15. Warncke SH, Mattei A, Fuechsel F, Z’Brun S, Krause T, Studer UE. Detection rate and operating time required for γ probe guided sentinel lymph node resection after injection of technetium-99m nanocolloid into the prostate with and without preoperative imaging. Eur Urol 2007;52:126–133.

    Article  PubMed  Google Scholar 

  16. Weckermann D, Dorn R, Holl G, Wagner T, Harzmann R. Limitations of radioguided surgery in high-risk prostate cancer. Eur Urol 2007;51:1549–1558.

    Article  PubMed  Google Scholar 

  17. Weckermann D, Wawroschek F, Harzmann R. Is there a need for pelvic lymph node dissection in low risk prostate cancer patients prior to definitive local therapy? Eur Urol 2005;47:45–51.

    Article  PubMed  Google Scholar 

  18. Wawroschek F, Wagner T, Hamm M, Weckermann D, Vogt H, Märkl B, et al. The influence of serial sections, immunohistochemistry, and extension of pelvic lymph node dissection on the lymph node status in clinically localized prostate cancer. Eur Urol 2003;43(2):132–137.

    Article  PubMed  Google Scholar 

  19. Wawroschek F, Vogt H, Weckermann D, Wagner T, Hamm M, Harzmann R. Radioisotope guided pelvic lymph node dissection for prostate cancer. J Urol 2001;166(5):1715–1719.

    Article  PubMed  CAS  Google Scholar 

  20. Wawroschek F, Vogt H, Wengenmair H, Weckermann D, Hamm M, Keil M, et al. Prostate lymphoscintigraphy and radio-guided surgery for sentinel lymph node identification in prostate cancer. Technique and results of the first 350 cases. Urol Int 2003;70(4):303–310.

    Article  PubMed  Google Scholar 

  21. Brenot-Rossi I, Bastide C, Garcia S, Dumas S, Esterni B, Pasquier J, et al. Limited pelvic lymphadenectomy using the sentinel lymph node procedure in patients with localised prostate carcinoma: a pilot study. Eur J Nucl Med Mol Imaging 2005;32:635–640.

    Article  PubMed  Google Scholar 

  22. Brenot-Rossi I, Houvenaeghel G, Jaquemier J, Bardou VJ, Martino M, Hassan-Sebbag N, et al. Nonvisualization of axillary sentinel node during lymphoscintigraphy: is there a pathologic significance in breast cancer? J Nucl Med 2003;44:1232–1237.

    PubMed  Google Scholar 

  23. Schwartz GF, Giuliano AE, Veronesi U; Consensus Conference Committee. Proceedings of the consensus conference on the role of sentinel lymph node biopsy in carcinoma of the breast, April 19–22, 2001, Philadelphia, Pennsylvania. Cancer 2002;94:2542–2551.

    Article  PubMed  Google Scholar 

  24. Alazraki N, Glass EC, Castronovo F, Valdés Olmos RA, Podoloff D. Procedure guideline for lymphoscintigraphy and the use of intraoperative gamma probe for sentinel lymph node localization in melanoma of intermediate thickness 1.0. J Nucl Med 2002;43:1414–1418.

    PubMed  Google Scholar 

  25. Eshima D, Fauconnier T, Eshima L, Thornback JR. Radiopharmaceuticals for lymphoscintigraphy: including dosimetry and radiation considerations. Semin Nucl Med 2000;30:25–32.

    Article  PubMed  CAS  Google Scholar 

  26. Wengenmair H, Kopp J, Wawroscheck F, Grober S, Dorn R, Heidenreich P. Pelvic lymph node diagnosis in prostatic carcinoma: biokinetics and dosimetry of 99mTc-nanocolloid after intraprostatic injection. Nuklearmedizin 2002;41:102–107.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Nuclear Medicine, Institut Paoli-Calmettes, Regional Cancer Center, Université de la Méditerranée, 232 Bd. Sainte Marguerite, 13273, Marseille Cedex 9, France

    Isabelle Brenot-Rossi & Guillaume Chuto

  2. Department of Urology, Hospital of the University of Marseille, CHU Nord, Université de la Méditerranée, Marseille, France

    Dominique Rossi & Cyrille Bastide

  3. Department of Statistics, Institut Paoli-Calmettes, Regional Cancer Center, Université de la Méditerranée, Marseille, France

    Benjamin Esterni

  4. Department of Radiology, Institut Paoli-Calmettes, Regional Cancer Center, Université de la Méditerranée, Marseille, France

    Serge Brunelle

Authors
  1. Isabelle Brenot-Rossi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Dominique Rossi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Benjamin Esterni
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Serge Brunelle
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Guillaume Chuto
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Cyrille Bastide
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Isabelle Brenot-Rossi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Brenot-Rossi, I., Rossi, D., Esterni, B. et al. Radioguided sentinel lymph node dissection in patients with localised prostate carcinoma: influence of the dose of radiolabelled colloid to avoid failure of the procedure. Eur J Nucl Med Mol Imaging 35, 32–38 (2008). https://doi.org/10.1007/s00259-007-0516-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00259-007-0516-0

Keywords

Search

Navigation